Roche navify Tumor Board  (2023):透過整體數據視圖改進腫瘤委員會會議,以促進多學科團隊協作並優化治療決策
市場調查報告書
商品編碼
1381003

Roche navify Tumor Board (2023):透過整體數據視圖改進腫瘤委員會會議,以促進多學科團隊協作並優化治療決策

Roche navify Tumor Board 2023: Improving Tumor Board Meetings with a Holistic View of Data That Facilitates Multidisciplinary Team Collaboration and Optimizes Care Decisions

出版日期: | 出版商: KLAS Research | 英文 5 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢
簡介目錄

腫瘤委員會會議在癌症患者的全面有效管理中發揮重要作用。這次會議將涉及多學科團隊共同評估複雜的癌症病例並做出明智的個人化治療決策。如果沒有腫瘤板技術,有效的溝通、協作、數據共享和決策可能會受到阻礙,導致延誤、不準確和次優護理。羅氏旨在透過 navify Tumor Board 解決這些潛在問題。

本報告提供Roche Diagnostics所提供的解決方案,以navify Tumor Board為焦點,並調查使用過此解決方案的客戶的第一印象和客戶體驗。

目錄

第1章 navify Tumor Board:客戶體驗 (CX) - 第一印象

第2章 應該考慮的點

第3章 Roche Diagnostics:企業簡介

第4章 解決方案的技術規格 (Roche Diagnostics提供)

簡介目錄

Tumor board conferences play a crucial role in the comprehensive, effective management of cancer patients. These meetings involve a multidisciplinary team that collectively evaluates complex cancer cases and collaborates to make informed, personalized treatment decisions. The absence of tumor board technology can hinder effective communication, collaboration, data sharing, and decision-making, which potentially leads to delays, inaccuracies, and suboptimal care. Roche aims to solve these potential problems with navify Tumor Board. This report offers an initial look at customers' experiences with this product.

Table of Contents

1.) navify Tumor Board Customer Experience: An Initial Look

2.) Points to Ponder

3.) Roche Diagnostics: Company Profile at a Glance

4.) Solution Technical Specifications (provided by Roche Diagnostics)